Research Letter: PDF OnlySevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery UnitNaqvi, Mariam MD; Burwick, Richard M. MD, MPH; Ozimek, John A. DO; Greene, Naomi H. PhD; Kilpatrick, Sarah J. MD, PhD; Wong, Melissa S. MD, MHDSAuthor Information Cedars-Sinai Medical Center, Los Angeles, California. Corresponding author: Mariam Naqvi, MD, Division of Maternal Fetal Medicine, Department of Obstetrics & Gynecology, Cedars-Sinai Medical Center, Los Angeles CA; email: firstname.lastname@example.org. Financial Disclosure Sarah J. Kilpatrick disclosed receiving funds from Contemporary OB/GYN, Keneka, and ACOG. She has also served as a board examiner for ABOG. The other authors did not report any potential conflicts of interest. Each author has confirmed compliance with the journal's requirements for authorship. Peer reviews and author correspondence are available at http://links.lww.com/AOG/B918. Received April 27, 2020 Received in revised form May 01, 2020 Accepted May 04, 2020 Obstetrics & Gynecology: May 19, 2020 - Volume Publish Ahead of Print - Issue - doi: 10.1097/AOG.0000000000003987 Free PAP Metrics Universal testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) yielded no positive results in asymptomatic women admitted to a Los Angeles labor and delivery unit. © 2020 by The American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.